Join the 'Biliary Tract and Hepatic Tumor' group to help and get support from people like you.
Biliary Tract and Hepatic Tumor News
Posted 8 May 2014 by Drugs.com
THURSDAY, May 8, 2014 – Just over two years ago, Melinda Bachini decided she was done with chemotherapy to treat her cholangiocarcinoma – a rare cancer of the bile duct that runs from the liver to the intestines. At that point, she'd gone through three rounds of chemo, with little to show for it except side effects. The cancer was in her liver and lungs, and the outlook was grim. "I knew if I was going to beat this, it would have to be with an experimental therapy," said Bachini, a mother of six who was diagnosed at the age of 41 – on her son's 14th birthday. So Bachini did what most of us do when we want information: She went online, where she "stumbled upon" a clinical trial at the U.S. National Cancer Institute (NCI). It was testing an experimental therapy against advanced cases of gastrointestinal cancers; the idea was to use people's own immune system T-cells to fight their ... Read more
Related support groups: Biliary Tract and Hepatic Tumor
Posted 14 Jan 2009 by Drugs.com
WEDNESDAY, Jan. 14 – New research may one day help physicians identify those patients with gastrointestinal cancers who are most likely to benefit from certain treatments. The discoveries, paving the way toward an era of personalized medicine, could save the U.S. health-care system millions while sparing patients the agony of receiving treatments that aren't going to help them. "These are a diverse group of tumors," said Dr. Jennifer C. Obel, an attending physician at NorthShore University Health System in Illinois, who moderated a Tuesday teleconference on the findings. "More than 270,000 people are diagnosed with GI [gastrointestinal] malignancies in the U.S. every year, and about 135,000 succumb to these illnesses on a yearly basis. How do we distinguish those patients most likely to benefit from treatment and screening than those who are not?" The findings come from four studies ... Read more